Member Info for Bobtastic

They're both at a similar stage towards production, they both are going to drill an appraisal well and establish the full contents of their respective basins, for sure he1 will have more reserves, however hex operates in the US close to end markets in chips space and MRI and are getting full ask on he, he1 will be selling to the Chinese for half the price with an immature industry base and setup costs

3.5 billion shares in issue and already 80mil market cap v 12mill MC and 100mil shares in issue that's why

Hahahaha ok plonker

Doubt we'll hear anything till after the 4th April once offer is formally closed and dusted, do they need these funds to scale or have they been able to sell some in the meantime is the question??

We already have FDA clearance for capture and harvesting for downstream analysis, this is a simple ldt to give clinicians data to assess a patient's illness and then approve FDA cleared drugs already in existence, We're good to go

Ctdna has great benefits in the way it helps the clinicians fully form their prognosis, in the sense it gives a great understanding of how effective the current form of drugs is working on the cancer, but as it's heterogeneous you need constant monitoring of the both substrates as it will behave differently to the drugs month after month, the NGS part is still huge as it's more than half as good again in detecting full variety of genetic markers giving the option for multi pronged attacks

Kobald have been focused on Zambia and Canada this year, although well funded they're still a relatively small company with their own limited manpower resources available!! They won't walk away with 49% as they have to spend 21million in exploration by December 31st 24 if they don't they forfeit the JV rights!!

They repeatedly state they are on the verge of a globally significant nickel deposit and the other two are predominantly copper

Have you raised your concerns with the nomad and FCA?

It's obviously an excuse, but they're only a relatively small outfit themselves!! They've been busy doing their African an Canadian assets and obviously put us on the back burner till next year!! As to the jv they forfeit their rights to disko if they don't drill by December 24

On Hargreaves they have a new proxy voting system it's under the message tab or just direct message your broker and ask for them

I agree and have voted them out at the agm the drilling campaign is obviously on the back burner to salvage the cash, however they have money to last until March providing they don't drill kanger themselves this year!! Dundas should be due soon as well as rio drilling in Finland so plenty to be going on with to support any activities this year!! Kobold just announced 195million capital raise so drilling will definitely go ahead next year along with terms of the jv

It's undoubtedly been poor but we had 7.4mil this time last year probably more like 2mil now, that's enough to get us to next march and raise with kobolds drill at disko announcement as per the contract with the jv!! It's another lost year but the lights will stay on

They got that massive sulfide boulder from a rock slide there didn't they!! It's there an kobald have already intimated their scans showed previously unidentified showings meaning it could even be bigger than previously thought, however nothings proven till the drill starts turning very very excited about the possibilities there

Sorry clia for ovarian ldt is a must services based could come under research and therefore exempt

Tbf I think your right sandy as most of those 20 clients he said were pharma based which is research led, which means they are exempt from fda clia approval!! We absolutely do need clia for accreditation to do human tests as that will be classed as high complexity!! My thinking was clia first but you probably right which is better for us as once certificates are stamped it can take months for the fda to send them back for final verification for actual lab usage

Some monster trades sneaked in today roughly 600k pounds worth an not moved the share price an inch?? Must be buys as surely they'd crash the price otherwise!!
Hopefully satago is about to go fully live with Lloyds an sage!! Interesting times lay ahead

And yes this is the diagnostic test clia and ukas will need in order to certify labs for testing

We've done two previous 200 patient studies to perfect our hycead chemical array system from harvesting ctcs via parsortix with the last one with an auc-roc of 95% which is classed as clinically excellent!! The only difference from the one we're waiting for is its blinded as far as I can see!! So triaging patients with malignant or benign plevic masses to appropriate surgeons and then retrospectively analysing lumps to confirm if the mass was indeed benign or malignant

There are many codes already established for pulmonary scans etc all with overlapping or broad terminology cpt 78579 78580 78582 seems to focus on xenon tho so I'm sure these could be piggybacked onto!! However cpt31615 could be used in conjunction!! Basically it's not a new field of medicine just a different type of machine used for imaging so codes an tools already exist

Cpt-76376 and Cpt-3766 should cover it as broadly speaking it's just a lung imaging scan which already is catered for, albeit ours is just a more enhanced image!! It's upto to consultant to read and interpret any image they see ie choose what device they use